| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q04DX003 (ip) | median survival time | saline | 7.5 mg/kg/injection | 471.0 | Antitumor endpoint evaluated on day 90; 08/08 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | saline | 7.5 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 15.0 mg/kg/injection | 308.0 | Antitumor endpoint evaluated on day 90; 08/08 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | saline | 15.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 471.0 | Antitumor endpoint evaluated on day 90; 08/08 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 150.0 | Antitumor endpoint evaluated on day 75; 09/09 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | saline | 30.0 mg/kg/injection | 273.0 | Antitumor endpoint evaluated on day 60; 07/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 471.0 | Antitumor endpoint evaluated on day 90; 07/08 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 193.0 | Antitumor endpoint evaluated on day 75; 10/10 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | saline | 60.0 mg/kg/injection | 335.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 5 |
| Q04DX003 (ip) | median survival time | saline | 120.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 90; 05/08 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | saline | 120.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 75; 07/10 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | saline | 120.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 5 |